ML21054A148
| ML21054A148 | |
| Person / Time | |
|---|---|
| Site: | Palisades  |
| Issue date: | 02/11/2021 |
| From: | Summers S Entergy Nuclear Operations |
| To: | Document Control Desk, Office of Nuclear Security and Incident Response |
| Shared Package | |
| ML21054A147 | List: |
| References | |
| Download: ML21054A148 (2) | |
Text
- - l J S NR C FFD Program Performance Data Reporting System NRC Form 891. Annual Reporting Form for Drug and Alcohol Tests I
f',, !
fin:,: I', o,*i/,
11,lff fl*,' I,1111 1 ui,
!F1L r;f' lkl cl1 c...; 11b 1ss Oil Por1cllJ APPROVED BY 0MB: CLEARANCE NO. 3150-0146 EXPIRES: 04/30/2021 Estimated burden per respon"' lo comply wilh lhis collection requesl is 108 hours0.00125 days <br />0.03 hours <br />1.785714e-4 weeks <br />4.1094e-5 months <br />. This form is a volunlary means of reporting lhe information required under 10 CFR 26.417(b)(2) and 26.717. The information is required by NRC lo obtain on an annual basis ste specific filness-for-duty (FFD) program performance dala on drug and alcohol programs from licen"'8s and othe, entitie~ Send comments regarding burden estimate to lhe FOIA, Information Services Branch (T6-A10M), U.S. Nudea< Regulatory Commisson, Washington DC 20555-0001, or by e-mail lo lnfocollects Resource@NRC.gov and to lhe Desk Officer, Office of Information and Regulatory Affairs, NEOB-1020, (3150-0146), Office of Management and Bud~ Washington DC 20503. If a means used to impose information collection does not display a rurrenlly valid 0MB control number, lhe NRC may not conduct or sponsor, and a person is not required to respond to, the information oollection.
- 1) All fields required unless marked 'optional'
- 2) Use of Adobe Reader 8 or Isler Is required
- 3) Mouse over fields for additional Information Facility
!Palisades (50-255)
Tests Conducted In the Calendar Year Submission Update Period of Report 2020 Total Number of Tests Conducted Reason For Testing Licensee Employee ContractorsNendors Pre-Access 60 1,004 Random 417 120 For Cause 4
0 Post-Event 0
2 Follow-up 11 Total (Calculated) 492 1,163 j FFD Program Random Testing Population and Rate Total Number of Positive, Adulterated, Substituted, and Refusal to Test Results 6 I o I o I Average number of licensee employees Average number of contractors/vendors Total size of the random testing pool throughout the period (Calculated)
Annual random testing percentage achieved for the testing pool 1
6751 Laboratory Testing Does your program use a I Licensee Testing Facility?
No (Yes I No)
L. -------'
3261 1
1.001 53.61 HHS-Certified Laboratory (Primary)
Quest Diagnostics Incorporated Lenexa, KS 66219 I
HHS-Certified Laboratory (Backup)
'Quest Diagnostics lnco/jforated Norristown, PA 19403 Identify your Blind Perfonmance Test Sample supplier(s)
LIE_1_s_o_h_1y_L_a_b_s,_1_n_c._, _o_~_o_rd_,_M_S_3_e_6_5_5 __________________ __,
Substances Tested Did your program only test for NRC-required substances Iv Al!!Q at the NRG-specified minimum cutoff levels? (Yes/ No) es Special Analyses Testing Results Does your program conduct LOO testing penmitted in 26.163(a)(2)? (Yes I No) 11 Total Number of "Dilute" 1
Specimen Test Results (Optional)
~---~
Total Number of "Dilute" Specimens I (Special Analyses Testing Conducted) L ____
1_1 Substance Alcohol Cocaine Marijuana Amphetamines Opiates PCP Use NRC Cutoffs?
Ives Ives Ives Ives Ives Ives Initial Cutoff Annual Report Fonm (version 1.9.0 - January 2020)
Conflnnatory Cutoff Limit of Detection (LOD) Testing?
I Not Applicable Ives Ives Ives Ives Ives
-Page1 of2-Comment (Optional)
NRC Fonm 891
Substances Tested - continued Summary of Management Actions - 26.717(b)(8)
Summarize actions implemented to improve FFD program performance. As applicable, reference in the topic description audit reports, 30-day reports, and/or corrective action reports. If reporting information on more than three topics, select "Others" for Topic 3 to report any additional topics.
Topic 1
!Policies and Procedures 181 Add an additional Topic Topic2
!Program and System Management D Add an additional Topic Topic 1 Description In response to the pandemic, procedures were revised to incorporate the CDC guidelines for personal protection use.
Topic 2 Description An analysis of the data for 2020 was conducted and no programmatic weaknesses were found.
Person(s) Responsible for Information Provided Person 1 (required):
lscott I
!summers l
lAA/FFD Supervisor First Name Last Name Position Title ssumme1@entergy.com Company Email Address Person 2 (optional):
II 1r II First Name Last Name Position Title Company Email Address Final Step (Required) - NRG will consider this form authentic in accordance with 10 CFR 26.11 only when the "Validate & Lock" button has been selected and all errors (i.e., those highlighted in red) have been corrected. The "Validate & Lock" button will change to "Locked" after the data validation process has been successfully completed and the form is ready for submission.
Form Locked On:IFeb 11, 2021 at 3:22:26 PM
\\ Save to Local PC I\\ Print this Report Annual Report Form (version 1.9.0 - January 2020)
-Page2of2-NRG Form 891